Menu
Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
ISSN: 1177-8881
Editor-in-Chief: Prof. Dr. Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4145)
- Volume 18, 2024 (105)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Impact of Opioid-Free Anesthesia on Postoperative Quality of Recovery in Patients After Laparoscopic Cholecystectomy: A Randomized Controlled Trial [Letter]
Xue B
Drug Design, Development and Therapy 2024, 18:1529-1530
Published Date: 6 May 2024
Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway
Yang YY, Deng RR, Xiang DX
Drug Design, Development and Therapy 2024, 18:1499-1514
Published Date: 2 May 2024
Network Pharmacology and Molecular Docking Identify the Potential Mechanism and Therapeutic Role of Scutellaria baicalensis in Alzheimer’s Disease [Letter]
Yulion R, Andriani L, Aliyah SH
Drug Design, Development and Therapy 2024, 18:1497-1498
Published Date: 2 May 2024
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y, Yu X, Zhu R, Zhang M, Chen W, Ma Y
Drug Design, Development and Therapy 2024, 18:1469-1495
Published Date: 1 May 2024
Dose-Response Study of Phenylephrine for Preventing Spinal-Induced Hypotension During Cesarean Delivery with Combined Spinal-Epidural Anesthesia Under the Effect of Prophylactic Intravenous Ondansetron
Sun XX, Qian J, Fan JM, Liu L, Jin XF, Xiao F
Drug Design, Development and Therapy 2024, 18:1459-1467
Published Date: 30 April 2024